-
This Medical Stock Soared Over 80% In Pre-Market After Advancing Gene Therapy Program For ALS, Alzheimer's And Parkinson's Diseases
Tuesday, July 9, 2024 - 7:46am | 450Read More...In Tuesday’s pre-market trading, ANEW Medical, Inc. (NASDAQ:WENA) saw its shares surge nearly 80% following an announcement about the advancement of its patented Klotho gene therapy program for neurodegenerative disorders. What Happened: ANEW, a biopharmaceutical company that specializes in...
-
Comedian And 'Curb Your Enthusiasm' Fame Richard Lewis Dies At 76
Thursday, February 29, 2024 - 3:38am | 533Read More...Renowned comedian Richard Lewis, known for his role in HBO’s ‘Curb Your Enthusiasm’, has passed away at 76. What Happened: Lewis, celebrated for his self-deprecating humor, died at his Los Angeles residence on Tuesday night. His publicist, Jeff Abraham, confirmed that a heart...
-
Study Unveils Rare Cannabinoid As Promising Hope For Alzheimer's, Parkinson's & Huntington's Treatment
Thursday, June 1, 2023 - 3:47pm | 452Read More...The study focused on the potential of rare cannabinoids in the treatment of neurodegenerative diseases like Alzheimer's. According to the researchers behind the study, this breakthrough research opens new avenues for addressing the unmet medical needs of patients with conditions like Alzheimer...
-
Parkinson's Patients May Benefit From Ketamine, PharmaTher Applies For FDA Fast Track
Wednesday, May 3, 2023 - 7:08am | 326Read More...Specialty pharmaceutical company PharmaTher Holdings (OTCQB: PHRRF) has submitted a Fast Track Application to the Food and Drug Administration (FDA) for KETARX, a ketamine drug that may help treat levodopa-induced dyskinesia in Parkinson’s disease. Fast Track designation is for...
-
Worms Get The Munchies Like The Rest Of Us, Finds Study 'With Profound Implications For Human Health'
Thursday, April 20, 2023 - 8:40pm | 497Read More...A new study has confirmed that pot-smoking bipeds are not the only creatures that get the munchies. Worms apparently experience cravings for their favorite snacks after consuming cannabis. Researchers at the University of Oregon said the tiny nematode worms they used for the...
-
Elon Musk Says His Neuralink Chip Could Treat Paralysis, Stroke And Brain Injury
Sunday, April 24, 2022 - 12:43pm | 648Read More...Tesla Inc (NASDAQ: TSLA) CEO Elon Musk's startup Neuralink brain chip could help treat morbid obesity; that's what Musk believes. Echoing Musk's statement, scientists say it's not an impossibility. Responding to a Twitter post on the same line, Musk said that it is...
-
Alterity Therapeutics Highlights New Publications On ATH434 In Parkinson's Disease
Friday, January 28, 2022 - 12:02pm | 251Read More...Alterity Therapeutics's (NASDAQ: ATHE) data in an animal model of Multiple System Atrophy (MSA) were published in the Journal of Parkinson's Disease. The publication describes a study evaluating the efficacy of ATH434 in genetically altered mice that develop manifestations of...
-
FDA Grants Fast Track Designation For Prevail's Parkinson's Treatment
Monday, July 8, 2019 - 10:43am | 224Read More...Prevail Therapeutics (NASDAQ: PRVL) shares are trading higher after the company received FDA fast track designation for PR001 for the treatment of Parkinson's disease patients with a GBA1 mutation. “We are pleased that the FDA has granted Fast Track Designation for PR001, which...
-
Seelos Therapeutics Shares Rally Following Deal For Gene Therapy Program
Thursday, June 27, 2019 - 9:17am | 146Read More...Seelos Therapeutics (NASDAQ: SEEL) shares traded higher after news emerged the company acquired the license of gene therapy program to address Parkinson's disease from Duke University. The gene therapy program targets the regulation of the SNCA gene. Seelos plans to study this approach, named...
-
Why Seelos Therapeutics Shares Are Surging Out Of The Gate
Friday, March 29, 2019 - 2:43pm | 423Read More...Thinly traded nanocap biotech Seelos Therapeutics Inc (NASDAQ: SEEL) is trading sharply higher on over three times its average volume. The company recently completed a reverse merger with Apricus Biosciences, and its shares have been trading under the ticker symbol SEEL. What Happened...
-
EPA Amends Proposed Regulation Of Syngenta Ingredient In Response To Public Comments
Wednesday, December 28, 2016 - 4:29pm | 697Read More...The Environmental Protection Agency is acting to mitigate health risks of paraquat dichloride — an herbicide commonly used in Syngenta AG (ADR) (NYSE: SYT) products — in response to fatalities from chemical ingestion and extended exposure. Paraquat Dichloride: More Than Just A Plant...
-
Goldman Initiates Impax Labs With Sell Rating, $33 Target
Monday, June 6, 2016 - 11:46am | 322Read More...Although Impax Laboratories Inc (NASDAQ: IPXL)'s prospects have improved since the remediation of its manufacturing issues in 2015, Goldman Sachs’ Stephan Stewart believes “the fundamental outlook is fully reflected in the stock,” and there could be “increased competition...
-
IBM Teams Up With Pfizer To Move Towards Parkinson's Cure
Thursday, April 7, 2016 - 1:47pm | 336Read More...International Business Machines Corp. (NYSE: IBM) and Pfizer Inc. (NYSE: PFE) announced on Thursday a collaboration to develop monitoring solutions aimed at transforming how health care providers deliver care to patients suffering from Parkinson's disease. According to IBM's press...
-
Acadia Continues Huge Rise Following FDA Panel Vote
Wednesday, March 30, 2016 - 7:52am | 177Read More...Shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) were trading higher by more than 22 percent early Wednesday morning. A U.S. Food and Drug Administration panel voted 12-2 on Tuesday that Acadia's drug pimavanserin, a treatment for psychosis associated with Parkinson's disease,...












